bis(resorcylaldoximato)copper(II)

structure given in first source

Also Known As:

CuRES2 cpd; trans-bis(resorcylaldoximato)copper(II)

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Elo, Hannu: 1 article (11/2004)

1.	Neoplasms (Cancer) 11/01/2004 - "This compound as well as some congeners, most notably the 4-hydroxylated analogue trans-bis(resorcylaldoximato)copper(II), CuRES2, also have potent antiproliferative activity against tumor cells in vitro. "